Iran vs MENA Reporting Region: Percentage of surviving infants who received the third dose of hep
Iran
98
in 2025
MENA Reporting Region
85
in 2025
Iran rank
3rd
MENA Reporting Region rank
1st
Percentage of surviving infants who received the third dose of hep over time
- Iran
- MENA Reporting Region
How they compare
Iran currently reports 98 against 85 in MENA Reporting Region, a difference of 13.
That makes Iran's figure about 1.2 times MENA Reporting Region's.
Across all 32 years both countries report, Iran has been ahead every year.
Iran ranks 3rd and MENA Reporting Region ranks 1st of 20 countries.
Iran has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Iran | MENA Reporting Region | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 81.17 | 54.33 | 26.83 | Iran |
| 2000s | 97.2 | 83.9 | 13.3 | Iran |
| 2010s | 98.8 | 89 | 9.8 | Iran |
| 2020s | 98.5 | 85.83 | 12.67 | Iran |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of surviving infants who received the third dose of hep, Iran or MENA Reporting Region?
- Iran, at 98 against 85 in MENA Reporting Region as of 2025.
- What is the difference in percentage of surviving infants who received the third dose of hep between Iran and MENA Reporting Region?
- 13, with Iran ahead.
- How many years of comparable data are there for Iran and MENA Reporting Region?
- 32 years are reported by both, from 1994 to 2025.
- How do Iran and MENA Reporting Region rank globally for percentage of surviving infants who received the third dose of hep?
- Iran ranks 3rd and MENA Reporting Region ranks 1st of 20 countries.
- Where does this data come from?
- UNICEF, published as Percentage of surviving infants who received the third dose of hep B-containing vaccine. Statizoid refreshes it automatically from the source and publishes the full history for both places.